M&A Deal Summary

Medtronic Acquires Sapiens Steering Brain Stimulation

On August 26, 2014, Medtronic acquired medical products company Sapiens Steering Brain Stimulation from Gilde Healthcare and Edmond de Rothschild Private Equity for 200M USD

Acquisition Highlights
  • This is Medtronic’s 30th transaction in the Medical Products sector.
  • This is Medtronic’s 22nd largest (disclosed) transaction.
  • This is Medtronic’s 1st transaction in Germany.

M&A Deal Summary
Date 2014-08-26
Target Sapiens Steering Brain Stimulation
Sector Medical Products
Buyer(s) Medtronic
Sellers(s) Gilde Healthcare
Edmond de Rothschild Private Equity
Deal Type Add-on Acquisition
Deal Value 200M USD

Target

Sapiens Steering Brain Stimulation

Munich, Germany
Sapiens Steering Brain Stimulation GmbH is developing a Deep Brain Stimulation (DBS) system for patients suffering from brain disorders such as Parkinson’s disease. Sapiens’ innovative solution is an advanced DBS lead with 40 individual stimulation points.

Search 200,626 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Medtronic

Dublin, Ireland
Category Company
Founded 1949
Sector Medical Products
Employees95,000
Revenue 32.4B USD (2024)
DESCRIPTION
Medtronic's operational headquarters in Fridley, Minnesota.
Medtronic's operational headquarters in Fridley, Minnesota.

Medtronic is a global medical technology company whose products aim to alleviate pain, restore health, and extend life. It serves hospitals, physicians, clinicians, and patients in approximately 160 countries worldwide. Medtronic was founded in 1949 and is based in Dublin, Ireland with its operational headquarters in Fridley, Minnesota.

DEAL STATS #
Overall 34 of 59
Sector (Medical Products) 30 of 52
Type (Add-on Acquisition) 33 of 57
Country (Germany) 1 of 1
Year (2014) 5 of 6
Size (of disclosed) 22 of 36
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2014-07-28 Visualase

Houston, Texas, United States

Visualase, Inc. is a developer and marketer of an FDA-approved MRI-guided laser and image guided system for minimally invasive neurosurgeries, including surgical thermal ablation.

Buy $105M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2014-08-27 NGC Medical

Novedrate, Italy

NGC offers a broad suite of hospital managed services from infrastructure design and turnkey installation to material and equipment management. The company has approximately 100 employees.

Buy -

Seller(S) 2

SELLER

Gilde Healthcare

Investor Investor Investor Investor Investor

Category Private Equity Firm
Founded 1999
PE ASSETS 2.6B EUR
Size Large
Type Sector Focused
DESCRIPTION

Gilde Healthcare is a specialist private equity and venture investor focused on the healthcare sector. The Firm's buyout group targets majority investments throughout Europe (preference for Germany, the Netherlands, Belgium, Austria or Switzerland) and has a focus on healthcare providers, suppliers and service providers active in the healthcare market. The Firm's venture group looks to invest in early stage medtech, diagnostics, digital health and therapeutics companies throughout North America and Europe. Gilde Healthcare was established in 2001 and is headquartered in Utrecht, the Netherlands.

DEAL STATS #
Overall 12 of 30
Sector (Medical Products) 2 of 7
Type (Add-on Acquisition) 7 of 15
Country (Germany) 4 of 5
Year (2014) 3 of 6
Size (of disclosed) 5 of 10
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2014-08-06 Santaris Pharma A/S

Horsholm, Denmark

Santaris Pharma A/S is developing a diverse pipeline of LNA therapeutics that influence the production or activity of select RNA targets to address diseases that are difficult-to-treat with conventional drug modalities. Santaris uses its proprietary Locked Nucleic Acid (LNA) platform and tissue-targeting expertise to pioneer next-generation antisense product candidates.

Sell $250M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2014-09-19 ProQR Therapeutics

Leiden, Netherlands

ProQR Therapeutics is a biotech company focused on development of drugs to treat severe genetic disorders. ProQR Therapeutics was founded in 2012 and is based in Leiden, the Netherlands.

Sell -
SELLER

Edmond de Rothschild Private Equity

Investor

Category Private Equity Firm
PE ASSETS 1.2B EUR
Size Large
Type Sector Agnostic
DESCRIPTION

DEAL STATS #
Overall 9 of 27
Sector (Medical Products) 2 of 3
Type (Add-on Acquisition) 1 of 10
Country (Germany) 1 of 1
Year (2014) 3 of 4
Size (of disclosed) 1 of 6
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2014-08-01 Groupe ADF

Vitrolles, France

Groupe ADF is a provider of industrial engineering and maintenance services. Groupe ADF specialising in three business lines engineering & expertise, the supply of production and testing equipment, and production & maintenance services. Groupe ADF serves the Aeronautics, Space & Defense Industry, Energies, Oil & Gas sectors. Groupe ADF is based in Vitrolles, France.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2014-09-01 EUROP NET

Nanterre, France

EUROP NET is recognized as the specialist in cleanliness and multiservice in the Île-de-France region. EUROP NET has been offering a wide range of services to guarantee the hygiene, the cleaning, the maintenance and the reception of your workspaces.

Buy -
Mergr

Product

Company

Legal